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Immunization with endotoxin stimulates the production of specific antibody, 
however it does not provide the high level of specific protection conferred by the 
exotoxins. In addition to their antigenic activity, endotoxins elicit other char- 
acteristic reactions which are extensive and varied. Such effects may influence 
host resistance more significantly than does the stimulation of specific antibody. 
A  non-specific increase in resistance to infection with various bacterial patho- 
gens and  a  reduction  or elimination  of such reactions  as fever,  Shwartzman 
phenomena or lethality have been shown to follow injection of endotoxin. This 
altered  host  reactivity  usually  is  of  short  duration  and  is  independent  of 
demonstrable antibody. 
Although  the  mechanisms  of  such  resistance  have  remained  obscure  for 
many years, recent studies on the humoral  and cellular alterations in the host 
which  follow  the  administration  of  endotoxins  may provide  meaningful  in- 
formation. 
In this connection,  the effect of endotoxin on serum properdin and on the activity 
of the reticuloendothelial system (RES) are noteworthy. Endotoxin has been shown 
(2) to increase the resistance of mice to experimental infections;  there is a concomitant 
increase  in serum properdin levels (3) and an enhanced ability of the RES to clear 
injected colloids or bacteria from the blood (4). However, these effects by themselves 
are not likely to account for the altered state of resistance (5). 
In studies on the interactions, in vitro  and in vivo, between endotoxins and properdin, 
attention in the past has been focused on the changes produced in properdin and the 
components of complement. More recent studies (6-9) have been concerned  with the 
resultant change in endotoxin itself as a  consequence  of its interaction with serum. 
We have described  a heat-labile component of serum, other than complement, pro- 
perdin, or specific antibody, which altered endotoxic materials so that they no longer 
could elicit their characteristic host responses  (1). 
* Reference 1 is the first paper of this series. 
~; National  Institutes  of Health,  Public Health  Service, United States  Department  of 
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This  paper  and  the  following  one  (10)  record  further  information  on  this 
humoral  component.  In  this  communication,  data  are  provided  on  its  oc- 
currence in the serum of various mammalian species and on the relative potency 
of serum and  plasma  from the  same individual.  The conditions  for the  inter- 
action of this humoral component with endotoxin,  and  the bioassay  technique 
necessary for the disclosure of the resultant  reduction in activity of endotoxin, 
are described. 
Materials and Methods 
Endotoxins.--The  tumor-necrotizing polysaccharide isolated from Serratia marcescens (Lot 
No. P-25)  was employed in most of the experiments. In special situations other endotoxins 
were used which had been derived by various techniques, from colonially smooth or rough 
forms of Salmondla and Escherichia. The sources of these endotoxins are listed in Table V 
together with references to the publications which describe their properties. 
Serum and Plasma.--Human  blood specimens were obtained from healthy adult donors and 
allowed to clot at room temperature. After 1 hour the clots were rimmed and the serum de- 
canted and clarified by centrifugation. Plasma was obtained by drawing blood into an anti- 
coagulant solution  (ACD,  1 unless otherwise stated);  the formed elements were removed by 
centrifugation. Pools of serum or plasma were prepared from fifty or more donors, transferred 
to tubes and flame-scaled,  and stored at --20°C. 
Animals.--Etherized  mice and  rats  were  exsanguinated  by  bleeding directly from  the 
heart; blood from groups of ten or more was pooled to provide sufficient volumes of serum 
or plasma. In the case of other species  (rabbit, guinea pig, dog, horse, and sheep)  blood from 
individual animals was used unless otherwise indicated.  Plasma was obtained by collecting 
the blood in trisodium citrate  (3.8  mg./ml.). These specimens were also stored at  --20°C. 
in sealed pyrex tubes. 
Interaction of Endotoxin with Serum or Plasma.--For  measuring the capacity of serum or 
plasma to inactivate endotoxin, varying amounts were incubated with a  standard  quantity 
of the Serratia marcescens endotoxin at pH 7.4 to 8 for 1 hour at 37°C. The quantities of re- 
actants employed were, in all instances, sufficient for subsequent assay in groups of ten mice 
each. In these assays, each mouse received as routine 10/~g. of this endotoxin (see following 
section on assay). A constant volume (0.10 ml.) of a stock solution of endotoxin containing 
1,000/~g.  per ml., enough for ten mice, was incubated with undiluted serum or plasma. After 
incubation, the volume was made up to 5.0 mi. with saline so that the amount administered 
intraperitoneally to each mouse was kept constant at 0.5 ml. The variable in these assays was 
the quantity of serum or plasma incubated with this fixed amount of endotoxin. The above 
procedure provided the material for injection into ten mice, but it is emphasized that the data 
are given in terms of the quantities administered per mouse. For example, when 0.1  ml. of 
plasma was incubated with 0.1 ml. of the stock solution of endotoxin and was then diluted to 
5.0 ml., the 0.5 ml. aliquot given to each mouse represented the products of reaction of 10 
/~g. of endotoxin and 0.01 ml. of plasma. 
Assay of Endotoxin Detoxifying Component (EDC).--The procedure employed for assess- 
ment of induced damage in tumor tissue was that employed in this Laboratory for many years 
(11).  Sarcoma 37 tumor mash (0.05 ml.) was implanted in the thigh muscle of 2 or 3 month 
old CAF1 mice. On the 6th day of tumor growth the mice were randomly distributed into 
groups of 10; usually 200 mice were implanted at the same time with allquots of the same 
I The formula is 22 gin. trisodium citrate, 8 gm. citric acid, and 25 gin. dextrose per liter 
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tumor mash. Each such set of bioassays contained two control groups---an untreated one for 
determination of the presence or absence of spontaneous hemorrhage or necrosis, and a second 
one given !0 #g. of the endotoxin in saline for ascertaining the level of responsiveness of the 
tumors in each lot of 200 mice. This amount of the Serf. marcesccns endotoxin was usually 
sufficient to induce marked hemorrhage and necrosis in the tumors of all mice in the group, 
and yet was small enough so that diminution  of its potency could be detected. Mter incuba- 
tion of graded volumes of serum or plasma with endotoxin as described above, 0.5 ml. aliquots 
of each test mixture were injected, intraperitoneally, into each of 10 mice. The animals were 
necropsied on the following day for examination of the tumors. 
The tumors  were inspected  under low power magnification (XS)  and induced  tumor 
damage in the experimental groups was scored with reference to the two control groups. 
When the extent of tumor damage was undistinguishable from that in the endotoxin control 
group, no significant inactivation had occurred. When no tumor damage was evident in any 
of the tumors in a group, the endotoxin had been inactivated. Intermediate degrees of tumor 
damage, or evidence of damage in only some of the tumors, showed that partial inactivation 
had occurred. 
GeneraL--The findings reported in the present study are based on experiments repeated, 
in one form or another, many times. These involved an extensive series of assays in w~ich more 
than 10,000 mice were used. The data obtained with this test system based on response of 
tumors were so voluminous that it is impractical to present them in full detail. Therefore the 
results of approximately 1,000 individual assays in tumor-bearing mice are given in summary 
form, except for certain illustrative protocols. 
Until such time as its chemical nature is elucidated, we have, for convenience, assigned a 
functional designation to this humoral agent. For the time being, we shail refer to it as "en- 
d0toxin-detoxifying component"  or EDC. 
EXPERn~ENTAL 
Inactivation of ErMotoxin by Scrum.--We previously reported (1) that human 
sera, upon incubation with endotoxin, alter these polysaccharide complexes so 
that they no longer evoke the characteristic host responses. This effect of serum 
was shown to extend to a  number of endotoxic materials irrespective of their 
derivation, e.g.,  those  obtained from  tissues  of  higher plants and mammals 
(12), as well as from Gram-negative bacteria. The quantity of human serum re- 
quired  to  inactivate Serr.  marcescens  endotoxin, as  measured  in  the  tumor 
damage assay, varied significantly among donors. For example, 0.1 ml. or less 
of some sera was sufficient to inactivate 10 #g. of endotoxin, while with other 
sera quantities ranging up to 0.5 ml. were required to bring about comparable 
inactivation. A  few sera were encountered which did not inactivate endotoxin 
even at a level of 0.5 ml., the largest amount tested as routine. Sera from mice 
and rabbits were ineffective in altering endotoxin, while sera from the horse 
and guinea pig were comparable to human serum in their effects upon endo- 
toxin. 
It was demonstrated (1) that other host reactions caused by endotoxins were 
similarly affected  after  incubation in vitro  of  endotoxin and  human serum. 
Endotoxin, so altered, no longer prepared for the local Shwartzman reaction, no 
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and  no  longer  produced  fatal  collapse  in  rabbits.  Heat-inactivated serum, 
similarly incubated with  endotoxin, failed  to  abolish  these  properties.  It  is 
therefore clear that  serum contains a  heat-labile system which  is  capable of 
producing striking alterations in endotoxins. 
Distinction  between EDC  and  Other  ttumoral  Components.--Among  the 
humoral components known to  react  with  endotoxins are  specific antibody, 
complement,  and  properdin.  It  was  therefore  necessary  to  determine  what 
influence, if any, these substances had on the reported inactivation of endo- 
toxins. 
Accordingly, serum was rendered deficient in each of these components. Properdin was re- 
moved by treatment with zymosan at 17°C. for 1 hour (13), or bound by addition of an ap- 
propriate amount of rabbit antibody to human properdin (14). Elimination  of the components 
of complement was effected by standard procedures (15, 16) : serum deficient in CI (Rt) was 
prepared by dialysis for 48 hours against acetate buffer of pH 5.5, #  =  0.02 at 0°C.; R~ by 
heating serum for ~  hour at 52°C. (this procedure also inactivates the heat-sensitive factor 
(17)); R4 by treatment with 9 mg hydrazine at 37°C. for 1 hour (this concentration of hy- 
drazine also removes the hydrazine-sensitive factor (17)); complement-fixed (CF) serum by 
incubation with preformed antigen-antibody complex (18) (Pneumococcus  Type III polysac- 
charide-rabbit anti-Type HI serum); and streptokinase-treated  (SK) serum (19) by incuba- 
tion of serum with streptokinase  (vaxidase, Lederle).  Divalent cations  were removed  by 
treating equal  volumes of  fresh  human serum with 6 m~r EDTA for 45 minutes at 37°C. 
When required, reagents were checked for absence of hemolytic  activity against  sensitized 
sheep red cells and then tested  for EDC activity with the  assay procedure described. 
To determine whether specific antibody was implicated in the effect of fresh 
serum  on  a  given  endotoxin  (i.e.,  from  Serratia  marcescens  or  Salmonella 
typhosa),  the  following tests  were  performed. 
Fresh serum was examined for the presence of specific antibody in agglutination tests with 
the bacteria from which the endotoxin had been derived, and in hemagglutination tests with 
red cells which had been coated with homologous  endotoxin. The sera employed were found to 
contain little or no antibody demonstrable by these methods. Moreover, the addition  of 
specific anti-typhoid rabbit serum to incubated mixtures of human serum and endotoxin did 
not alter  the subsequent inactivation of this endotoxin. Furthermore,  the tumor-damaging 
potency of typhoid endotoxin itself was not diminished in the presence of specific antibody. 
The removal, by adsorption, of Serr. marcescens  antibody from human serum did not alter its 
inactivating  potency for the endotoxin from this organism. Aliquots of serum or plasma were 
rendered deficient in one component, ~iz. properdin or one of the components of complement, 
and were in every instance still fully active. 
These findings are summarized in Table I  and indicate that none of  these 
known agents is responsible for such inactivation  in ~itro of endotoxin. 
Comparison  of EDC  Activity in  Serum  and  Plasma.--The  possibility was 
considered  that  the  component of  blood  responsible for  the  anti-endotoxic 
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For this reason, blood was collected at 37°C. in siliconized glassware to avoid the use of 
anticoagulant. The plasma was carefully separated from the cellular elements by low speed 
centfifugation and the cell-free plasma collected in citrate to prevent clotting. The btttty coat 
was washed with saline to remove plasma; the leucocytes were then ruptured  by alternate 
freezing and thawing. 
TABLE  I 
Effevt of Removal  of Humoral Components  on Inactivation  of Endotoxin  by Serum  or Plasma 
Effect on inactivation 
Component  Method of removal  of endotoxin 
Anti-properdin; zymosan  Properdin 
Complement  C~ 
C8 
l  C, 
Antibody 
Dialysis 
52°C.  for ~  hr. 
Zymosa/1 
Hydrazine 
None 
cl 
Specific adsorption  " 
TABLE  II 
Comparison  of EDC Activity in Paired Specimens of Serum and Plasma 
Volume required to inactivate* 
Species  10 #g. of Serf. marc~¢o~ endotoxin 
Human  ................................ 
Chimpanzees ........................... 
Horse .................................. 
Sheep .................................. 
Dog ................................... 
Rabbit ................................. 
Guinea pigs ............................ 
Rat:[: ................................... 
Mouse~ ................................ 
Serum 
0.1-0.5 
0.3 
0.4 
>0.5 
0.5 
>0.5 
0.5->O.5 
0.02 
>0.5 
Plasma 
ml. 
0.005-0.03 
0.01 
0.05 
0.05 
0.02 
0.01 
0.20 
0.01 
0.01 
* As measured in the tumor damage assay. 
:~ Pooled. 
This extract of buffy coat, in contrast to the cell-free plasma, was without 
effect on endotoxin, showing that EDC did not derive from blood cells.  Upon 
testing the cell-flee plasma at appropriate levels it became evident that this 
plasma exhibited far more EDC activity than serum. This marked contrast was 
convincingly demonstrated in the following manner. 
Each blood sample from donors of various species was divided into two aliquots; one was 
allowed to clot, while the other was collected in citrate. These paired specimens were then 
assayed for EDC activity; the results are given in Table II. The data are expressed in terms of 690  INACTIVATION  OF  ENDOTOXIN  BY  HUMORAL  COMPONENT.  II 
the minimum volume of serum or plasma required for inactivation of the standard mount of 
endotoxin as measured in the tumor damage assay. Since the largest amount of serum tested 
as routine was 0.5 mi., a value of >0.5 ml. indicates that the test serum was without measur- 
able EDC activity. 
Human sera varied considerably in  activity; an occasional specimen pro- 
duced little inactivation at 0.5 ml. but most specimens were effective in amounts 
ranging from 0.1  to 0.4 ml. Sera of the chimpanzee, horse, and dog were gen- 
erally comparable to human sera whereas those from sheep, rabbits, and mice 
were  without  measurable  effect.  However,  except  for  the  rat,  the  plasma 
aliquots from all species were highly effective in contrast to the paired serum 
aliquots which usually showed little or no effect. It is noteworthy that  the 
plasma EDC  activity was similar for eight of the nine species examined. In 
only one species, the rat,  was high activity consistently exhibited by serum 
(0.01-0.1 ml.): this finding was aifirmed in four different strains of this species. 
Examination of a  small number of citrated samples of human plasma had 
shown that the minimal amount required to inactivate I0 Izg. Serf. marcescens 
endotoxin ranged from 0.005  to 0.03  ml.  To obtain further information on 
levels of EDC  in  normal  humans,  citrated plasma  from 35  donors was  ex- 
amined. The plasma specimens were tested at 0.02 ml., a level considered to be 
within an expected range of EDC  activity. This quantity of each of the 35 
specimens sufficed to inactivate the standard dose of endotoxin. Levels of EDC 
were followed in three selected subjects over periods of I  to 7 months. EDC 
activity in the plasma of these individuals was found to be constant, within the 
experimental error of the assay. In contrast, serum specimens drawn from these 
same individuals over a period of many months were found to vary significantly 
in EDC potency. 
Conditions for  Interaction  between  EDC  and gndotoxin.--The  influence of 
experimental conditions on the inactivation of endotoxin by EDC was studied. 
In the determination of the requirements for inactivation, in vitro,  it became 
evident that a  number of factors importantly affected the outcome of the in- 
teraction. The influence during incubation of time, temperature, and pH was 
investigated. The quantity of Serf.  marcescens  endotoxin was  kept constant 
at 10 ~g. for the interaction with two different volumes of plasma; viz., 0.01 
mi., a small but not limiting amount and 0.1 ml., a substantial excess. 
Influence of Incubation Time, Temperature, and pH.--The time required for 
inactivation of the standard dose of endotoxin was dependent upon the amount 
of EDC present. At a low level (0.02 ml. of plasma), 20 minutes incubation at 
37°C. was needed to inactivate 10 #g. of the standard endotoxin, whereas at 
0.1 ml., 10 minutes sufficed. 
With the duration of incubation and the volume of plasma kept constant at 
60 minutes and 0.01  ml., respectively, the temperature was varied from 4  to 
45°C.  At the lower temperatures (4,  20,  and 30°C.)  no inactivation was ob- SKARNES,  ROSEN~ SHEAR,  AND  LANDY  691 
servable. At 37 and 45°C. inactivation was complete. In an excess volume of 
plasma  (0.1  ml.),  partial  inactivation  of  the  10  #g.  was  obtained  at  30°C. 
The effect of pH on EDC activity was examined over the range between 5 and 
9.  Endotoxin was inactivated at pH values of 7.5 through 9, but at pH 6 or 
TABLE III 
Influence on EDC Activity of Incubation Time  Temperature, and pH 
Volume of plasma 
incubated with 
10 #g. endotoxln* 
ml. 
0.02 
0.01 
0.01 
None(endotoxin in 
saline) 
None(no endo- 
toxin) 
Conditions of interaction 
Time  I  remperature I 
rain.  °C. 
0  37 
S 
10 
15 
2O 
6O  20 
30 
37 
45 
60  37 
60  37 
7.6 
7.6 
5.0 
6.0 
7.0 
7.5 
8.0 
9.0 
7.0 
Induced tumor 
damage:[: 
9/9 
7/9 
6/10 
3/io 
O/lO 
9/9 
8/9 
0/10 
0/10 
8/10 
4/9 
1/9 
O/9 
O/9 
0/9 
s/10§ 
O/lOll 
Inactivation  of 
endotoxin 
None 
~t 
Partial 
t~ 
Complete 
None 
st 
Complete 
None 
Partial 
Complete 
~c 
ct 
* Serf. marcescens,  Lot P-25. 
:~ No. of mice with damaged tumors/total No. of mice tested. 
§ Control group for endotoxie effect of 10 ug. of endotoxin alone. 
f] Control group for tumors in untreated mice. 
below  inactivation  was  incomplete  or  absent.  Even  when  a  tenfold  larger 
quantity  (0.1  ml.)  of plasma  was  employed, only partial inactivation of the 
endotoxin occurred at pH 6 and none was evident at pH 5. The results of these 
experiments are recorded in Table III. 
Influence  of Concentration of Reactants.raThe  EDC  activity of plasma was 
found to be influenced appreciably by dilution prior to incubation with endo- 
toxin. Thus, inactivation of the standard dose of endotoxin was brought about 
by 0.01 ml. of undiluted plasma, while three times this amount was required 
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The inactivation of endotoxin by plasma to a  degree below that detectable 
in  the  tumor  response assay does not  necessarily signify total  inactivation. 
For example, 10 #g. of endotoxin reacted with 0.01  ml. of plasma exhibited no 
endotoxic activity. On the other hand, when two or three times this quantity 
was reacted with 0.02  or 0.03  ml. of plasma, respectively, endotoxic activity 
was still present. This indicated  that in the first situation  a  small amount of 
endotoxin remained unaltered and that this unchanged material could be de- 
tected only when the absolute quantity of endotoxin was sufficiently great. This 
interpretation is based on results obtained in the titration of the tumor-damag- 
TABLE IV 
Effect of Concentration on Lability of EDC to Heat 
Volume of plasma incubated  Induced tumor  Inactivation of endotoxin  with lOug. of endotoxin*  Pretrcatmcnt  of plasma  damage:~ 
ml. 
0.3 
0.2 
0.05 
0.01 
0.01 
None (endotoxin in saline) 
None (no endotoxin) 
56 C. for 1 hr. 
None 
0/9 
2/9 
4/9 
7/9 
0/9 
8/10§ 
0/1011 
Complete 
Partial 
c~ 
None 
Complete 
* Serf. marcescens, Lot P-25. 
~: No. of mice with damaged tumors/total No. of mice tested. 
§ Control group for endotoxic effect of 10/,g. of endotoxin alone. 
I] Control group for tumors in untreated mice. 
ing  activity of Serf.  marcescens  endotoxin  itself,  in  which  less  than  3  #g.  of 
endotoxin ordinarily induced no tumor damage. 
Stability of EDC.--Serum  or plasma stored for several months at either -  55 
or -20°C. exhibited the same EDC potency as freshly drawn samples. Human 
plasma retained its full endotoxin-inactivating capacity after storage for more 
than two months at 4  to 8°C.; its activity began to decline somewhat after 4 
months. 
Human serum, after heating at 56°C. for 1 hour, could no longer inactivate 
10/~g. of endotoxin at a volume of 0.3 to 0.5 ml. Human plasma (collected in 
ACD), heated in the same manner and tested at the same volumes, appeared to 
be heat-stable. However, when tested at an appropriately low level, EDC was 
seen to be heat-labile in plasma also. In general, 0.01 ml. of human plasma ex- 
hibited  about  the  same potency in  inactivating  endotoxin  as did 0.4  ml.  of 
human serum. It is seen from Table IV that when a minimally effective volume SKARNES~  ROSEN,  SHEAR~ AND  LANDY  693 
of plasma was taken for test, both serum and plasma were found to be equally 
sensitive to heat. 
Interaction of EDC with Various Bacterial Endotoxins.--The initial observa- 
tions in this work were made with Serf.  marcescens  endotoxin,  and thereafter 
this product was  used as reference  material. Endotoxins obtained from dif- 
ferent sources, and prepared by different  techniques,  were also investigated. 
We had found (1) that human serum could inactivate endotoxic substances not 
only from bacteria but also from tissues of mammals and higher plants. 
In the present study the tumor-damaging potency of seven bacterial  endo- 
toxins was determined before and after incubation with plasma. 
TABLE  V 
Quantity  of Human Plasma Required  to Inactivate  Various  Endotoxins 
Preparation 
Westphal (20) ........... 
"  (20) ........... 
Raynand (21) .......... 
Staub (22) ............. 
Webster (23) ........... 
Westphai (20) .......... 
Shear (24) ............. 
Endotoxin 
Source 
Organism 
S. sdtottmudleri 
S. enleriditis 
S. typhosa R-2 
S. typhosa  901 
S. typhosa  901 
E. coil 018 
Serf. raarcescens 
Colonial type 
Rough 
cl 
Smooth 
c~ 
Minimum 
dose 
inducing 
tumor 
daraag e 
t~g. 
15 
10 
10 
3 
3 
3 
10 
Volume of 
pl~ma 
required for 
inactivation 
ml. 
0.5* 
0.5* 
0.5 
0.05 
0.02 
0.4 
0.01 
* Partial inactivation at this level. 
First the potency of these products, i.e.  the smallest quantity required for induction of 
hemorrhage and necrosis m  tumors, was assayed and found to vary somewhat for the seven 
endotoxins tested.  Then  each of  the  endotoxins was incubated with different volumes of 
pooled human plasma,  and assayed again in tumor-bearing mice. The quantity d  plasma 
which sufficed  to abolish the tumor-damaging effect of each of  the endotoxins is given in 
Table V. 
It is seen that endotoxins  prepared from different sources and by different 
methods varied considerably  in their alterability by EDC. Three of the four 
products  derived  from  colonially  smooth  bacteria  were  inactivated  with 
relatively small mounts of plasma. In contrast, all three products derived from 
colonially  rough variants required  large  mounts of plasma  to  affect their 
tumor-damaging activity. Of these three endotoxins from rough variants, that 
from S. typhosa required the maximum volume of plasma employed; even this 
volume effected only partial inactivation of the other two products from rough 
Salmonella. The potency of these endotoxins for induction of tumor damage was 
not related to their sensitivity to EDC action. To what extent these and other 694  INACTIVATION  OF ENDOTOXIN BY HUMORAL COMPONENT. II 
properties of endotoxins are a consequence not only of their source but also of 
the techniques of isolation is not known. 
Attempts to Prepare EDC-Free Plasma.--Preliminary attempts were made to 
remove EDC from plasma by adsorption with Gram-negative bacteria. Human 
plasma was incubated at 4, 20, and 37°C. with washed cell suspensions of heat- 
killed Salmonella typhosa and of viable Salmonella typhosa, Salmonella typhi- 
murium, Salmonella newport, and Escherichia coll. Adsorption for 18 hours at 
4°C. resulted in little or no reduction in EDC activity of the plasma. Adsorp- 
tion for 2 to 4 hours at 20 or 37°C. released endotoxin from the bacteria, as 
shown by the acquisition of potency to induce tumor damage by this adsorbed 
plasma  itself. Although it is possible that EDC is adsorbed in this manner, it 
was not feasible to obtain  evidence on this point inasmuch as the endotoxin 
released from the adsorbing bacteria interfered. 
DISCUSSION 
Endotoxins contribute significantly to the  toxic state  characteristic of in- 
fection  with  Gram-negative  bacteria.  Despite  constant  exposure  to  these 
noxious  substances,  mammals  usually  are  free  from  their  known  harmful 
effects. Recently attention has been directed to the capacity of endotoxins to 
alter the natural state of resistance of experimental animals to infection. In- 
terest has been focused on alterations in the level of properdin in serum and in 
the phagocytic activity of the reticulo-endothelial system (RES). This and the 
following paper (10) describe some of the characteristics of an additional hu- 
moral component which may also be involved in host resistance inasmuch as it is 
widely distributed among mammalian species and is capable, in vitro, of render- 
ing endotoxins innocuous. 
Although the endotoxin-modifying action of blood components has received 
much attention, its assessment has been restricted largely to changes in pyro- 
genicity.  Moreover,  the  reports  on  such  alterations  in  pyrogenic potency 
following exposure to serum, plasma, or formed elements have been contradic- 
tory. 
Thus,  several  investigators have described  augmentation  of pyrogenicity while 
others have reported its neutralization or reduction.  ~  In the latter category, Hegemann 
has published  a series of papers describing the neutralization of endotoxin by human 
serum as shown by absence of pyrogenicity for man (6, 26, 27). Maximal neutrali- 
zation required incubation in fresh serum for 8 to 12 hours; however,  when these 
mixtures were tested in rabbits, the fever activity was found to be reduced rather 
than abolished.  These findings were confirmed, in part, by Goodale and associates 
(28) who also found that the pyrogenicity for man of an endotoxin was significantly 
The voluminous  literature on this subject is covered in detail in the excellent review on 
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reduced upon incubation for 3 hours with fresh serum or heparinized plasma. How- 
ever, we have observed (29) that incubation for only 1 hour was sufficient to reduce 
the  pyrogenicity of endotoxin  for rabbits  when  citrated plasma was  used. 
Although  the  tumor response procedure for evaluating inactivation differs 
considerably  from  that  of pyrogenicity,  it  is  likely  that  the  same  humoral 
system is involved in both situations: the findings were similar with regard to 
heat lability, non-dialyzability, and variability among animal species. On the 
other  hand,  Hegemann's finding  that  prolonged  incubation  was  essential  to 
bring about reduction  or loss of activity stands  in contrast  to an incubation 
period of less than 1 hour which we found to suffice. 
Ho and Kass (8) found that serum or plasma from man, rat, or rabbit "attenuated" 
the lethality for rats of crude toxic extracts from S. typhosa; however, this effect was 
not observed with Boivin-type endotoxins.  They showed further that neither specific 
antibody nor properdin was required for this attenuation but that incubation for 3 
hours was necessary to obtain consistently a  partial protection of rats.  In our ex- 
perience, purified Boivin-type endotoxins were readily inactivated after only brief 
incubation. 
It is  difficult  to reconcile  these apparent discrepancies  inasmuch as  the  experi- 
mental conditions  varied in so many important respects, e.g. the source and means of 
isolation of endotoxin,  the species  of animal from which  the serum or plasma was 
drawn, the species employed for bioassay and the technique used to measure change 
in potency of altered endotoxin. 
Rowley reported that an alkaline phosphatase in the serum of several mammalian 
species split phosphate from endotoxin (7). This serum activity differed from the one 
reported here in that it had a narrow pH optimum and was largely dependent upon 
the presence of divalent cation (Ca  ++ or Mg++). He demonstrated this cation de- 
pendency by passing the serum through a cationic exchange resin, followed by treat- 
ment with  EDTA.  These procedures  greatly decreased  the  serum  activity which 
Rowley studied, whereas these were  the same procedures employed by us  (10) to 
greatly  increase  the  EDC  potency of serum. The  relationship  of such phosphate 
cleavage to the biologic  inactivation of endotoxin remains to be demonstrated. In 
any event, it is evident that requirements for activity in these two situations are of 
opposite nature. 
The alterations produced by blood in the properties of endotoxins have been 
examined by many investigators,  of whom some employed serum or plasma 
while some used both. Until now, no difference between serum and plasma has 
been reported with respect to diminution of endotoxic activity. This difference 
which is described in the present work was not evident in previous investigations 
for two reasons: (a) pyrogenicity was usually taken as the principal indicator of 
endotoxin  alteration,  and  (b)  heparin  was  used  as  the  anticoagulant  in  the 
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does not differ from serum in its ability to inactivate endotoxin, whereas citrated 
plasma does. 
Although the nature of the anticoagulant is of prime importance this, by it- 
self, is not sufficient to account for failure of this difference between serum and 
plasma to have become evident--the methods by which endotoxin activity is 
usually measured were not likely to reveal differences of this magnitude. Those 
reactions of laboratory animals to endotoxins which have been the  object of 
such intensive study in recent years were found to be unsuitable as bioassay 
methods for this particular purpose.  Though these reactions  are  capable  of 
demonstrating the differences (cf.  the following paper)  once they were estab- 
lished by means of tumor response, they did not provide sufficiently consistent 
data to serve for quantitation. A major difficulty is the well recognized vari- 
ability of response  among individual animals  to  a  given dose  of  the  same 
material; this is particularly true of the rabbit. 
These various reactions were examined by us for suitability as quantitative 
methods for measuring endotoxin. Lethality as an indicator was discarded when 
we found that it was not sensitive enough since it required a  relatively large 
dose of endotoxin which, moreover, was too variable even in the controls to 
serve for the prompt recognition of inactivation. These considerations applied, 
in varying degrees to 10-day-old chick embryos, to mice and to rabbits. Local 
skin reactions in rabbits,  both the customary Shwartzman phenomenon and 
the epinephrine potentiation of endotoxin, were examined but were found to be 
inconsistent because of variations among individual animals. 
The pyrogenic response of rabbits, widely employed as an indicator of endo- 
toxin activity was also examined. We found it to represent a special, if not an 
anomalous, situation. Under conditions in which endotoxin, after incubation 
with  citrated plasma,  was  found to  be  inactive in  the  induction of  tumor 
damage,  in  preparatory  potency in  the  local  Shwartzman reaction,  and  in 
lethal effects for thorotrast-prepared  rabbits,  it was still capable of eliciting 
fever of substantial magnitude (29). The reason for this seeming paradox is at 
present obscure, but at any rate these findings suggest that conclusions based on 
pyrogenicity in rabbits do not necessarily apply to other host reactions to en- 
dotoxin. 
To meet the requirements of  the present  study,  the  induction of hemor- 
rhagic necrosis in mouse Sarcoma 37 was employed. This reaction has been 
used in this Laboratory for many years as a measure of the potency of poly- 
saccharides isolated at first from Gram-negative bacteria and, more recently, 
from mammalian tissues. In mice of known genetic constitution, tumor damage 
was readily and consistently induced with microgram quantities of purified 
endotoxic polysaccharides. Despite  the limitations (11)  of the reaction as a 
quantitative assay method for such endotoxic materials, it was found to pro- 
vide results of sufficient sensitivity and uniformity to be useful for the study of 
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The m3mmalian host possesses a number of humoral factors which react with 
endotoxins. These include specific antibody and a number of non-specific sub- 
stances such as properdin, complement and the detoxifying component (EDC) 
described in this communication. Although each of these components can be 
shown to undergo different reactions with cndotoxin, the possibility is now con- 
sidered that these agents and perhaps still others do not function separately in 
the animal. It may be that they participate in a highly integrated series of re- 
actions by which the host progressively modifies endotoxin to  the point  at 
which it is rendered inactive. 
SUMMARY 
A humoral substance which inactivates endotoxin in vitro has been shown to 
be clearly distinguishable from complement, properdin, and specific antibody. 
For the present, it is designated "endotoxin-detoxifying component" or EDC. 
Animal species could be grouped in three categories with regard to the EDC 
activity of their sera; rat serum was highly potent; chimpanzee, dog, horse, and 
guinea pig sera were much less active; mouse, rabbit, and sheep sera exhibited 
no activity. The EDC potency of human sera varied widely, ranging from high 
to barely discernible activity. In contrast to the variations of EDC potency in 
serum, citrated plasma from all species manifested high potency of about  the 
same magnitude. 
The influence of time, temperature, pH, and concentration of reactants  on 
the inactivation of endotoxin by EDC was examined. EDC activity in plasma 
and serum was found to be labile to heating at 56°C.  for 1 hour.  Bacterial 
endotoxins, derived by different isolation procedures from smooth and  rough 
Gram-negative species,  varied considerably in susceptibility to EDC  action. 
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